Daily LY2811376 treatment was associated with muscle spindle loss in the tibialis anterior muscle of wild-type and heterozygous Bace1 mutant animals compared with corresponding vehicle-treated groups. In aged wild-type mice, oral LY2811376 reduced hippocampal sAPPβ levels compared with vehicle. Proteomic analysis showed that LY2811376 did not alter mouse plasma sVEGFR3 compared with vehicle treatment. In the inverted grid test, LY2811376-treated wild-type mice lost their footing faster than vehicle-treated animals. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Muscle spindle loss in treated animals
Animal study · Adult (P180) wild type [1]
Adult wild-type animals received LY2811376 daily at 100 μg/g of body weight/day for 29 consecutive days. Quantification in the tibialis anterior muscle showed loss of 40% of muscle spindles in wild-type and heterozygous Bace1 mutant animals compared with corresponding vehicle-treated groups.
Conditions shared by the study groups
- Treatment course
- daily with Ly2811376 at a dose of 100 μg/g of body weight/day for 29 consecutive days
- Vehicle
- pharmasolve (ISP technologies Inc), and aliquots were diluted 1/16 in corn oil
- LY2811376 100 μg/g of body weight/day
- Model: Adult (P180) wild type
- Reported limits: Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: LY2811376
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Bace1 activity is required to sustain muscle spindles and to maintain motor coordination (S20, S22); Materials and methods > Bace1 inhibition in adult mice (S120, S121); Figure 2 legend (S199)
Quantification of muscle spindles in the tibialis anterior muscle: Quantification of muscle spindles in the tibialis anterior muscle; comparator: corresponding vehicle-treated groups — Results > Bace1 activity is required to sustain muscle spindles and to maintain motor coordination (S22); Figure 2 legend (S199)
LY2811376 100 μg/g of body weight/day · Results > Bace1 activity is required to sustain muscle spindles and to maintain motor coordination (S22); Materials and methods > Bace1 inhibition in adult mice (S121)
Reduced Hippocampal sAPPβ Levels in Aged Wild-Type Mice
Animal study · aged wild‐type C57BL/6 mice; 18–20 months; aged: n = 5 [2]
Aged wild-type mice received the study compound at 100 mg/kg body weight by oral gavage. At 12 h after treatment, hippocampal sAPPβ levels normalized with β-actin were reduced compared with vehicle.
Conditions shared by the study groups
- Route
- oral gavage
- Treatment course
- 12 h after the treatment
- Vehicle
- 10% DMSO, 40% PEG300, 5% Tween‐80, and 45% saline
- LY2811376 100 mg/kg body weight
- Model: aged wild‐type C57BL/6 mice; 18–20 months; aged: n = 5
Methods and source locations
Compound reported in the paper: LY2811376
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Age‐related increase in βAPP processing contributes to higher GluN2B synaptic contribution (S52); METHODS > BACE1 inhibitor (S66, S67, S68); FIGURE 5 legend (S229, S235)
sAPPβ levels normalized with β‐actin: sAPPβ levels normalized with β‐actin; comparator: vehicle — RESULTS > Age‐related increase in βAPP processing contributes to higher GluN2B synaptic contribution (S52); FIGURE 5 legend (S235)
LY2811376 100 mg/kg body weight · RESULTS > Age‐related increase in βAPP processing contributes to higher GluN2B synaptic contribution (S52); METHODS > BACE1 inhibitor (S67); FIGURE 5 legend (S229, S235)
Treatment Did Not Alter Plasma sVEGFR3 in Mice
Animal study · mice (n = 13, treated; n = 14, veh) [3]
Mice received treatment at 100 mg/kg, with vehicle-treated mice as controls. Proteomic analysis of murine plasma showed that treatment did not alter sVEGFR3.
- LY2811376 100 mg/kg
- Model: mice (n = 13, treated; n = 14, veh)
- Reported limits: Not stated in the sentences used: route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: LY2811376
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > sVEGFR3 is a pharmacodynamic activity marker for BACE2 in vivo. (S76, S77); Figure 6 legend (S265)
proteomic analysis of murine plasma: proteomic analysis of murine plasma; comparator: vehicle-treated mice — Results > sVEGFR3 is a pharmacodynamic activity marker for BACE2 in vivo. (S77); Figure 6 legend (S265)
LY2811376 100 mg/kg · Results > sVEGFR3 is a pharmacodynamic activity marker for BACE2 in vivo. (S76, S77)
Inverted grid performance in treated wild-type mice
Animal study · wild-type mice [1]
Wild-type mice received LY2811376 daily at 100 μg/g of body weight/day for 29 consecutive days. In the inverted grid test, treated animals lost their footing 3–4 times faster than vehicle-treated animals.
Conditions shared by the study groups
- Treatment course
- daily with Ly2811376 at a dose of 100 μg/g of body weight/day for 29 consecutive days
- Vehicle
- pharmasolve (ISP technologies Inc), and aliquots were diluted 1/16 in corn oil
- LY2811376 100 μg/g of body weight/day
- Model: wild-type mice
- Reported limits: Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: LY2811376
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Bace1 activity is required to sustain muscle spindles and to maintain motor coordination (S26); Materials and methods > Bace1 inhibition in adult mice (S120, S121); Figure 2 legend (S200)
inverted grid test: inverted grid test; comparator: animals treated with the vehicle — Results > Bace1 activity is required to sustain muscle spindles and to maintain motor coordination (S26); Figure 2 legend (S200)
LY2811376 100 μg/g of body weight/day · Results > Bace1 activity is required to sustain muscle spindles and to maintain motor coordination (S26); Materials and methods > Bace1 inhibition in adult mice (S121)